HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 268 filers reported holding HAEMONETICS CORP in Q3 2020. The put-call ratio across all filers is 0.64 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $11,557,000 | +19.1% | 104,110 | +27.4% | 0.11% | +7.8% |
| Q4 2020 | $9,702,000 | +19.3% | 81,702 | -12.3% | 0.10% | +19.8% |
| Q3 2020 | $8,130,000 | -49.4% | 93,182 | -48.0% | 0.09% | -52.5% |
| Q2 2020 | $16,057,000 | +105.8% | 179,288 | +129.0% | 0.18% | +70.8% |
| Q1 2020 | $7,802,000 | -36.0% | 78,288 | -26.2% | 0.11% | -18.5% |
| Q4 2019 | $12,190,000 | -1.7% | 106,088 | +7.9% | 0.13% | -5.1% |
| Q3 2019 | $12,398,000 | -15.5% | 98,288 | -19.4% | 0.14% | -16.0% |
| Q2 2019 | $14,668,000 | +1.7% | 121,888 | -26.1% | 0.16% | +0.6% |
| Q1 2019 | $14,424,000 | -15.1% | 164,888 | -2.9% | 0.16% | -22.1% |
| Q4 2018 | $16,997,000 | -12.7% | 169,888 | 0.0% | 0.21% | +8.3% |
| Q3 2018 | $19,466,000 | +21.2% | 169,888 | -5.1% | 0.19% | +18.5% |
| Q2 2018 | $16,056,000 | -6.6% | 179,038 | -23.8% | 0.16% | -9.0% |
| Q1 2018 | $17,195,000 | +4.2% | 235,038 | -17.3% | 0.18% | +8.5% |
| Q4 2017 | $16,503,000 | – | 284,138 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nitorum Capital, L.P. | 413,122 | $16,608,000 | 4.78% |
| Altalis Capital Management LLC | 88,055 | $3,540,000 | 3.97% |
| RUTABAGA CAPITAL MANAGEMENT LLC/MA | 513,619 | $20,647,000 | 3.54% |
| Black Creek Investment Management Inc. | 1,118,613 | $44,968,000 | 3.46% |
| HealthCor Management, L.P. | 1,150,000 | $46,230,000 | 2.61% |
| Van Berkom & Associates Inc. | 1,136,971 | $45,706,000 | 1.83% |
| AMERICAN CAPITAL MANAGEMENT INC | 567,896 | $22,829,000 | 1.77% |
| FULLER & THALER ASSET MANAGEMENT, INC. | 2,062,539 | $82,914,000 | 1.25% |
| Legato Capital Management LLC | 1,336 | $53,707,000 | 0.97% |
| HEARTLAND ADVISORS INC | 351,314 | $14,123,000 | 0.78% |